Is Pfizer Stock Undervalued?
Pfizer's (NYSE: PFE) revenue and earnings are skyrocketing, thanks in large part to the success of its COVID-19 vaccine. However, the big pharma stock hasn't delivered inspiring gains. In this Motley Fool Live video recorded on June 2, Motley Fool contributors Keith Speights and Brian Orelli answer a viewer's question asking if Pfizer stock is undervalued right now.
Source Fool.com


